Clinical Trial Update: Study of Metronomic Capecitabine and Oxaliplatin Versus XELOX in Egyptian Metastatic Colorectal Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial comparing metronomic capecitabine-oxaliplatin with XELOX in Egyptian metastatic colorectal cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• XELOX (capecitabine + oxaliplatin)
• capecitabine-oxaliplatin metronomic regimen

Snippet

Sponsor: National Cancer Institute, Egypt | Conditions: Clinical Response, Toxicity | Phase 2 | Status: COMPLETED